BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 228166)

  • 1. Reactivity of neutralizing antibodies with different specificities to H particles of poliovirus.
    Urasawa T; Urasawa S; Taniguchi K
    Microbiol Immunol; 1979; 23(7):651-7. PubMed ID: 228166
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monoclonal antibodies reactive with different sites of N and H antigenic particles of poliovirus.
    Taniguchi K; Urasawa S; Urasawa T
    J Gen Virol; 1983 Dec; 64 ( Pt 12)():2803-8. PubMed ID: 6198442
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of specificity of poliovirus inhibitors with inhibitor-resistant mutants of a strain of type 1 poliovirus.
    Hashimoto N
    J Immunol; 1975 Aug; 115(2):569-74. PubMed ID: 168261
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutations conferring resistance to neutralization with monoclonal antibodies in type 1 poliovirus can be located outside or inside the antibody-binding site.
    Blondel B; Crainic R; Fichot O; Dufraisse G; Candrea A; Diamond D; Girard M; Horaud F
    J Virol; 1986 Jan; 57(1):81-90. PubMed ID: 2416957
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Different virus-precipitating activities of neutralizing monoclonal antibodies that recognize distinct sites of poliovirus particles.
    Taniguchi K; Urasawa S
    Arch Virol; 1987; 92(1-2):27-40. PubMed ID: 2432854
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Further studies of specificity of antibodies contained in antiserum against poliovirus.
    Urasawa S; Urasawa T; Kanamitsu M
    Jpn J Microbiol; 1976 Feb; 20(1):11-6. PubMed ID: 178940
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antigenic variation of poliovirus caused by antibody components with different specificities.
    Urasawa S; Ishizawa F; Urasawa T
    Microbiol Immunol; 1977; 21(6):299-307. PubMed ID: 198635
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antigenic analysis of poliovirus type 3 using monoclonal antibodies.
    Ferguson M; Minor PD; Magrath DI; Schild GC
    Dev Biol Stand; 1984; 57():151-5. PubMed ID: 6098495
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monoclonal antibodies reveal in blocking reactions the antigenicity and antibody response of poliovirus.
    Uhlig H; Rutter G; Dernick R
    Dev Biol Stand; 1984; 57():187-91. PubMed ID: 6084610
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence for several unrelated neutralization epitopes of poliovirus, type 1, strain Mahoney, provided by neutralization tests and quantitative enzyme-linked immunosorbent assay (ELISA).
    Uhlig H; Rutter G; Dernick R
    J Gen Virol; 1983 Dec; 64 ( Pt 12)():2809-12. PubMed ID: 6198443
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monospecific antisera against capsid polypeptides of poliovirus type 1 distinguish antigenic structures of poliovirus proteins.
    Wiegers KJ; Dernick R
    J Gen Virol; 1983 Apr; 64 (Pt 4)():777-85. PubMed ID: 6300300
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of a poliovirus neutralization epitope through use of neutralizing antiserum raised against a purified viral structural protein.
    Emini EA; Dorner AJ; Dorner LF; Jameson BA; Wimmer E
    Virology; 1983 Jan; 124(1):144-51. PubMed ID: 6186073
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunochemical studies of polioviruses: identification of immunoreactive virus capsid polypeptides.
    Thorpe R; Minor PD; Mackay A; Schild GC; Spitz M
    J Gen Virol; 1982 Dec; 63(2):487-92. PubMed ID: 6185628
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of neutralizing antibodies by type 1 poliovirus VP1 capsid polypeptide.
    Crainic R; Blondel B; Horaud F
    Dev Biol Stand; 1983; 55():185-9. PubMed ID: 6329856
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structure of the complex between the Fab fragment of a neutralizing antibody for type 1 poliovirus and its viral epitope.
    Wien MW; Filman DJ; Stura EA; Guillot S; Delpeyroux F; Crainic R; Hogle JM
    Nat Struct Biol; 1995 Mar; 2(3):232-43. PubMed ID: 7539711
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neutralization epitopes on poliovirus type 3 particles: an analysis using monoclonal antibodies.
    Ferguson M; Minor PD; Magrath DI; Qui YH; Spitz M; Schild GC
    J Gen Virol; 1984 Jan; 65 ( Pt 1)():197-201. PubMed ID: 6198447
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of specificity of antibodies contained in antiserum against poliovirus with mutants resistant to inhibitors in equine serum.
    Urasawa S; Urasawa T; Kanamitsu M
    J Immunol; 1974 Aug; 113(2):537-42. PubMed ID: 4367633
    [No Abstract]   [Full Text] [Related]  

  • 18. Poliovirus neutralization epitopes: analysis and localization with neutralizing monoclonal antibodies.
    Emini EA; Jameson BA; Lewis AJ; Larsen GR; Wimmer E
    J Virol; 1982 Sep; 43(3):997-1005. PubMed ID: 6183443
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antigenic structure of polioviruses of serotypes 1, 2 and 3.
    Minor PD; Ferguson M; Evans DM; Almond JW; Icenogle JP
    J Gen Virol; 1986 Jul; 67 ( Pt 7)():1283-91. PubMed ID: 2425046
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Isolated poliovirus capsid protein VP1 induces a neutralizing response in rats.
    Chow M; Baltimore D
    Proc Natl Acad Sci U S A; 1982 Dec; 79(23):7518-21. PubMed ID: 6296837
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.